DC
CVS icon

Davenport & Co’s CVS Health CVS Stock Holding History

Davenport & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.08M Sell
39,412
-739
-2% -$66K 0.02% 411
2026
Q1 		$2.88M Sell
40,151
-2,516
-6% -$194K 0.02% 451
2025
Q4 		$3.39M Buy
42,667
+1,603
+4% +$126K 0.02% 415
2025
Q3 		$3.1M Sell
41,064
-692
-2% -$47.4K 0.02% 440
2025
Q2 		$2.88M Sell
41,756
-2,364
-5% -$155K 0.02% 441
2025
Q1 		$2.99M Buy
44,120
+1,501
+4% +$89.8K 0.02% 399
2024
Q4 		$1.91M Sell
42,619
-19,107
-31% -$1.07M 0.01% 489
2024
Q3 		$3.88M Sell
61,726
-29,298
-32% -$1.71M 0.02% 340
2024
Q2 		$5.37M Sell
91,024
-159,267
-64% -$9.96M 0.03% 286
2024
Q1 		$20M Sell
250,291
-34,325
-12% -$2.62M 0.12% 156
2023
Q4 		$22.5M Sell
284,616
-26,651
-9% -$1.9M 0.15% 135
2023
Q3 		$21.7M Sell
311,267
-28,727
-8% -$2.04M 0.16% 128
2023
Q2 		$23.5M Buy
339,994
+29,752
+10% +$2.12M 0.17% 125
2023
Q1 		$23.1M Sell
310,242
-9,936
-3% -$833K 0.18% 127
2022
Q4 		$29.8M Sell
320,178
-3,114
-1% -$300K 0.24% 110
2022
Q3 		$30.8M Buy
323,292
+6,904
+2% +$683K 0.27% 107
2022
Q2 		$29.3M Buy
316,388
+5,475
+2% +$534K 0.24% 109
2022
Q1 		$31.5M Sell
310,913
-31,370
-9% -$3.3M 0.22% 105
2021
Q4 		$35.3M Buy
342,283
+7,704
+2% +$712K 0.23% 105
2021
Q3 		$28.4M Buy
334,579
+67,436
+25% +$5.65M 0.2% 109
2021
Q2 		$22.3M Sell
267,143
-3,164
-1% -$259K 0.17% 114
2021
Q1 		$20.3M Buy
270,307
+205
+0.1% +$14.9K 0.19% 106
2020
Q4 		$18.4M Sell
270,102
-523
-0.2% -$34K 0.18% 109
2020
Q3 		$15.8M Sell
270,625
-1,540,914
-85% -$95.9M 0.18% 108
2020
Q2 		$118M Buy
1,811,539
+12,680
+0.7% +$798K 1.43% 14
2020
Q1 		$107M Sell
1,798,859
-492
-0% -$32.8K 1.54% 10
2019
Q4 		$134M Buy
1,799,351
+35,763
+2% +$2.51M 1.43% 15
2019
Q3 		$99.3M Sell
1,763,588
-21,763
-1% -$1.29M 1.19% 21
2019
Q2 		$97.3M Sell
1,785,351
-3,461
-0.2% -$186K 1.16% 25
2019
Q1 		$96.5M Buy
1,788,812
+282,316
+19% +$17.4M 1.2% 22
2018
Q4 		$98.7M Buy
1,506,496
+356,538
+31% +$26.6M 1.36% 15
2018
Q3 		$90.5M Buy
1,149,958
+44,673
+4% +$3.19M 1.05% 25
2018
Q2 		$71.1M Buy
1,105,285
+310,641
+39% +$20.5M 0.88% 34
2018
Q1 		$49.4M Buy
794,644
+63,845
+9% +$4.58M 0.61% 62
2017
Q4 		$53M Buy
730,799
+154,545
+27% +$11.2M 0.64% 57
2017
Q3 		$46.9M Buy
576,254
+7,551
+1% +$597K 0.59% 67
2017
Q2 		$45.8M Buy
568,703
+109,033
+24% +$8.61M 0.6% 65
2017
Q1 		$36.2M Buy
459,670
+35,862
+8% +$2.86M 0.52% 75
2016
Q4 		$33.4M Buy
423,808
+375,661
+780% +$30.4M 0.48% 88
2016
Q3 		$4.28M Buy
48,147
+1,775
+4% +$168K 0.06% 151
2016
Q2 		$4.44M Sell
46,372
-12
-0% -$1.2K 0.07% 150
2016
Q1 		$4.81M Sell
46,384
-96
-0.2% -$9.34K 0.08% 141
2015
Q4 		$4.54M Buy
46,480
+693
+2% +$67.9K 0.07% 150
2015
Q3 		$4.42M Buy
45,787
+10,794
+31% +$1.13M 0.07% 146
2015
Q2 		$3.67M Buy
34,993
+1,660
+5% +$170K 0.06% 168
2015
Q1 		$3.44M Sell
33,333
-499
-1% -$50.5K 0.05% 180
2014
Q4 		$3.26M Sell
33,832
-1,845
-5% -$163K 0.05% 177
2014
Q3 		$2.84M Buy
35,677
+497
+1% +$39.2K 0.05% 183
2014
Q2 		$2.65M Sell
35,180
-1,010
-3% -$76.3K 0.05% 187
2014
Q1 		$2.71M Buy
36,190
+255
+0.7% +$18K 0.05% 179
2013
Q4 		$2.57M Buy
35,935
+158
+0.4% +$10.2K 0.05% 179
2013
Q3 		$2.03M Sell
35,777
-27,406
-43% -$1.63M 0.04% 183
2013
Q2 		$3.61M Buy
+63,183
New +$3.66M 0.08% 139

Other funds holding CVS

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Davenport & Co's CVS Position: Q2 2026 in Review

Davenport & Co reduced its CVS Health (CVS) stake by 1.8% in Q2 2026, selling an estimated $66K and leaving 39,412 shares worth $4.08M. The position accounts for 0.02% of the portfolio, ranked #411.

Davenport & Co first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $134M in Q4 2019. 459 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Davenport & Co held 39,412 shares of CVS Health worth $4.08M as of Q2 2026.
  • Davenport & Co sold 739 CVS Health shares in Q2 2026, an estimated $66K.
  • CVS Health made up 0.02% of Davenport & Co's portfolio in Q2 2026, its #411 holding.
  • Davenport & Co first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Davenport & Co's CVS Health position peaked at $134M in Q4 2019.
  • 459 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.